Details for New Drug Application (NDA): 019616
✉ Email this page to a colleague
The generic ingredient in PENETREX is enoxacin. There are three drug master file entries for this compound. Additional details are available on the enoxacin profile page.
Summary for 019616
Tradename: | PENETREX |
Applicant: | Sanofi Aventis Us |
Ingredient: | enoxacin |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019616
Profile for product number 004
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
Approval Date: | Dec 31, 1991 | TE: | RLD: | No |
Profile for product number 005
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 400MG | ||||
Approval Date: | Dec 31, 1991 | TE: | RLD: | No |
Expired US Patents for NDA 019616
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi Aventis Us | PENETREX | enoxacin | TABLET;ORAL | 019616-005 | Dec 31, 1991 | 4,359,578 | ⤷ Subscribe |
Sanofi Aventis Us | PENETREX | enoxacin | TABLET;ORAL | 019616-004 | Dec 31, 1991 | 4,352,803 | ⤷ Subscribe |
Sanofi Aventis Us | PENETREX | enoxacin | TABLET;ORAL | 019616-005 | Dec 31, 1991 | 4,442,101 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription